Clinical trial
Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune…
NCT00225875 · Assistance Publique - Hôpitaux de Paris, Other · Terminated
Key facts
| NCT number | NCT00225875 |
|---|---|
| Title | Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and Candidate for a Splenectomy |
| Official title | Evaluation De l'Efficacité Du Rituximab (Mabthéra) Chez l'Adulte Atteint d'Un Purpura thrombopénique Auto-Immun Chronique Et sévère Et Candidat à La splénectomie |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Collaborators | Etablissement Français du Sang |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Autoimmune Thrombocytopenic Purpura |
| Intervention type | Drug |
| Interventions | Mabthéra |
| Enrollment | 65 |
| Start date | Sep 1, 2003 |
| Completion | Jul 1, 2007 |
| First posted | Sep 26, 2005 |
| Last update posted | Oct 27, 2005 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: